Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-002095
Accepted
2025-07-01 00:15:35
Documents
1
Effectiveness Date
2025-06-30

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-25-002095.txt   1746
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-288025 | Film No.: 251094056
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)